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Drug designMepA is amultidrug transporter from Staphylococcus aureus that confers multidrug resistance through the efﬂux
of a wide array of hydrophobic substrates. To evaluate the ability of MepA to recognize different substrates, the
dissociation constants for interactions between MepA and three of its substrates (acriﬂavine (Acr), rhodamine
6G (R6G), and ethidium (Et)) were measured. Given that MepA is puriﬁed in the presence of detergents and
that its substrates are hydrophobic, we examined the effect of the detergent concentration on the dissociation
constant. We demonstrate that all three substrates interact directly with the detergent micelles. Additionally,
we ﬁnd the detergent effect on the KD value to be highly substrate-dependent. The KD value for R6G is greatly in-
ﬂuenced by the detergent, whereas the KD values for Acr and Et are only modestly affected. The effect of the in-
active D183Amutant on binding was also evaluated. The D183Amutant shows lower afﬁnity toward Acr and Et.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Multidrug resistance (MDR) poses a growing health concern with
the rise of pathogenic bacteria that are resistant to antibiotics. The efﬂux
of drugs by transporters is a common mechanism for the emergence of
drug resistance [1,2]. Five superfamilies of multidrug exporters have
been identiﬁed so far: the small multidrug resistance (SMR) family [3],
the resistance nodulation and cell division family (RND) [4], the ATP
binding cassette family (ABC) [5], the major facilitator family (MFS)
[6], and the multidrug and toxic compound extrusion (MATE) family
[7]. The MATE family was the last to be identiﬁed and is the least well
characterized. NorM from Vibrio parahaemolyticuswas the ﬁrstmember
of theMATE family to be identiﬁed for its ability to confer aMDRpheno-
type [8]. In microorganisms, several MATE proteins have been found to
confer MDR through efﬂux of a wide variety of compounds [9–17]. A
number of MATE structures have been determined recently [18–20]
with some in complex with their substrates.
MepA is a member of the MATE family that was found to be
overexpressed in Staphylococcus aureus (S. aureus) strains with increased
resistance to various antibiotic compounds [21]. It was shown that over
expression of MepA confers MDR in S. aureus [22]. Similar to other
MATE transporters, MepA exports a variety of compounds that are struc-
turally diverse yet share common characteristics. Typically theMepA sub-
strates are hydrophobic, aromatic, and carry a delocalized positive charge.
These substrates include: acriﬂavine (Acr), ethidium (Et), rhodamine 6G
(R6G), benzyl alkonium, crystal violet, tetraphenylphosphonium (TPP),
4-6-diamidino-2-phenylindole (DAPI), dequalinium, and pentamidine[22]. Currently, there are no biochemical characterizations of MepA or
any information on binding to substrates.
In order to shed light on the ability of MepA to recognize and export
a wide array of substrates here we measured the binding of MepA to
three of its substrates: namely, acriﬂavine (Acr), ethidium (Et), and rho-
damine 6G (R6G). Due to the inherent hydrophobic nature of these sub-
strates and the fact that MepA is puriﬁed in the presence of detergent,
we also carried out a detailed study on the inﬂuence of the detergent
concentration on binding of these three substrates to MepA. Direct in-
teractions between the DDM micelles and the three substrates were
evaluated. We also measured the effect of the inactive D183A mutant
on substrate binding [23]. This mutation is expected to be far from the
substrate binding site, based on aMepAmodel that is derived fromaho-
mologous MATE structure [23]. All three substrates are intrinsically
ﬂuorescent, which allowed the use of ﬂuorescence polarization (FP) to
monitor their binding to the protein. In the case of Et, ﬂuorescence
enhancement was an additional tool used to monitor binding to
MepA. The detergent selected for this study was dodecyl-maltoside
(DDM), since it is a commonly used detergent, and becausemanymem-
brane proteins are stable in DDM [24,25].2. Materials and methods
2.1. MepA cloning, expression and puriﬁcation
Wild-type MepA was cloned from the Mu 50 strain of S. aureus into
a pBAD expression vector with an N-terminal 12-His tag. Protein
expression was carried out in E. coli Top10 cells as recommended
(tools.lifetechnologies.com/content/sfs/manuals/pbad_man.pdf) by
Invitrogen [26].
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pH 8.0, 150 mM NaCl, and 5% (v/v) glycerol) (buffer A). The cells
were ruptured by three passes through an M110-P microﬂuidizer
(Microﬂuidics) at 20 k psi, and the membranes were isolated by
ultra-centrifugation for 1 h at 42 k rpm (204,526 g) in an Optima
LE-80 k ultracentrifuge (Beckman Coulter) using a Ti-45 rotor, after
removing cell debris with a low speed centrifugation. Frozen mem-
braneswere solubilized in buffer A containing 2% (w/v) DDMdetergent
(Affymetrix) and 2 mM β-mercaptoethanol (BME). The concentration
of DDM is reported throughout the manuscript in terms of a (w/v) per-
centage. The DDM-solublized membranes were again centrifuged at 42
k rpm (204,526 g) in anOptima LE-80 k ultracentrifuge (BeckmanCoul-
ter) using a Ti-45 rotor for 1 h at 4 °C. 10mM imidazole and 2 ml of Ni-
NTA resin were added to the supernatant and the combined mixture
was kept stirred at 4 °C for 1 h. The resin was then applied to a gravity
ﬂow column and washed with 30 ml of (50 mM Tris pH 8.0, 150 mM
NaCl, 0.02%DDM, 2mMBME) (buffer B)with 30mM imidazole, follow-
ed by another 30mlwash step using the same buffer B but with 50mM
imidazole. Protein was eluted from the column in buffer B plus 450mM
imidazole (Fig. S1). The eluted protein was concentrated by centrifuga-
tion using 50 kMWCOAmicon Ultracel® (Milipore). The protein sample
was then applied to a Superdex 200 10/300 GL size exclusion column
(SEC; GE Healthcare) equilibrated with buffer B using an AKTA Puriﬁer
chromatography system (GE Healthcare). The peak fractions were col-
lected and analyzed with SDS-PAGE to conﬁrm sample purity
(Fig. S1). The fractions were then combined, concentrated, ﬂash frozen
under liquid nitrogen and stored at−80 °C. For binding assays, the pro-
tein was thawed and ultracentrifuged for 1 h at 60 K (127,814 g) in a
Beckman optima ultracentrifuge using a TLA120.1 rotor, to remove
any aggregates. The protein concentration was determined again, after
ultracentrifugation. Puriﬁcation of MepA in C12E8 was carried out in
the same manner as described for DDM, except that Anapoe-C12E8
was used in place of DDM.
2.2. DDM concentration determination
The concentrations of DDM in concentrated protein samples were
measured as described by Urbani [27]. Brieﬂy, 1.0% (w/v) phenol solu-
tion in concentrated sulfuric acid was prepared and kept on ice. DDM
standards were prepared with concentrations ranging from 0 to 2.0%.
DDM standards and the protein samples were dispensed in triplicate al-
iquots of 10 μl into disposable borosilicate tubes (Fisherbrand), and 1ml
of the phenol/sulfuric acidmixturewas added to each and vortexed. The
tubes were then covered with paraﬁlm and incubated at 45 °C for 3 to
5 h. After incubation, the A490 of the samples and standards were then
measured using a Genesys 20 spectrophotometer (Thermo Spectronic).
A calibration curve was constructed using the readings from the stan-
dards and ﬁt to a straight line using Excel. The DDM concentrations of
the unknown samples were determined by comparing to the standard
curve. The DDM concentrations in the MepA samples were between
0.6% and 1.2% DDM.
2.3. Whole cell activity assays
Cell based assays were performed using JW0451-2 cells (ΔacrB,
KmR) provided by the Keio Collection at Yale University. An empty
pBAD plasmid along with pBAD plasmids encoding wild-type and
D183A MepA were transformed into JW0451-2 cells (ΔacrB, KmR) and
grown overnight at 37 °C in LB media supplemented with ampicillin
(100 μg/ml) and kanamycin (50 μg/ml). These cultureswere used to in-
oculate 50 ml of LB (1:100 dilution) with ampicillin (100 μg/ml) and
kanamycin (50 μg/ml) and grown to an OD600 of 0.4. The temperature
was then lowered to 28 °C and 0.02% (w/v) of L-arabinose was added
to induce expression. After 3 h of induction, cells were collected by
centrifugation and washed three times with cell assay buffer (50 mM
Tris-HCl, pH 8.0, 150 mM NaCl) at room temperature and resuspendedin the same buffer to a ﬁnal OD600 of 1.0. A 1.5 ml aliquot of cell suspen-
sionwas centrifuged; the supernatant was discarded and the pellet was
stored at−20 °C. This sample was used as the zero time point for the
assay. Next, 100 μM ethidium bromide was added to the cells at room
temperature with stirring and protected from light. Aliquots of 1.5 ml
were collected and processed as before at time points of 5, 15, 30, 60
and 90min. The collected cell pellets were stored at−20 °C. The pellets
were thawed and resuspended in 150 μl of assay buffer with 5% (v/v)
trichloroacetic acid and vortexed for 30 s. The samples were then
centrifuged with a relative centrifugal force (rcf) of 21,100 g at room
temperature for 10 min to remove cell debris. Then the supernatants
were collected and transferred to a 96-well Microﬂuor 1 ﬂuorescence
plate (Fisher Scientiﬁc). The samples were then analyzed in a Spectra
Gemini XS ﬂuorescent plate reader (Molecular Devices) with excitation
and emission wavelengths set at 484 nm and 630 nm, respectively.
2.4. Fluorescence polarization and intensity binding assay
MepA protein was brieﬂy thawed at room temperature and placed
on ice, then concentrated by centrifugation using a 50 kMWCOAmicon
Ultracel® (Milipore) at 4 °C to a concentration of ~140 μM. Concentrat-
ed protein was then centrifuged at 65 k rpm in a TLA-120.1 rotor at 4 °C
for 45 min using an Optima TLX ultracentrifuge (Beckman Coulter) to
remove any precipitated protein and to ensure the removal of any
aggregation or mis-folded protein. The protein concentration of the su-
pernatant was measured using A280. Calibration using the Amido black
assay was performed according to Kaplan and Pedersen [28] to obtain
the protein concentration. The amido black assay has been shown to
be compatible with lipids and detergents [28–30]. A 40 μl aliquot of
the protein sample was set aside and stored at−80 °C for a DDM con-
centration assay. The binding assays were conducted using approxi-
mately 500 μl of buffer B to which 1 μM ethidium bromide was added.
Buffer B plus 1 μM ethidium bromide is called “Et buffer”; buffer B
plus 1 μMof R6G is called “R6Gbuffer”; buffer B plus 1 μMof Acr is called
“Acr buffer”. Eleven aliquots of 20 μl of Et buffer were dispensed into
Eppendorf tubes. Next, 1 μM of ethidium bromide was added to 40 μl
of protein sample and then 20 μl of this wasmixed into the ﬁrst 20 μl al-
iquot of Et buffer. After adequate mixing by pipette, 20 μl was removed
and mixed into the next tube containing Et buffer and this process was
repeated to perform 2-fold serial dilutions of the protein for all the
samples except the ﬁnal tube which was kept without any protein and
contained only Et buffer. The samples were protected from light with
aluminum foil and allowed to equilibrate for 20 min at room tempera-
ture. The same was done for R6G and Acr binding assays, except using
R6G buffer and Acr buffer, respectively.
The samples were analyzed in a FluoroMax-3 (Horiba Jobin) spec-
trophotometer using a 30 μl QS ﬂuorescence cuvette (1.50 mm,
Helma). Changes in the intensity and polarization of ethidium ﬂuores-
cence were measured using excitation and emission wavelengths of
483 nm and 630 nm, respectively. The excitation and emission
bandpasseswere both set to 10 nmand integration timewas 0.1 s. Fluo-
rescence data for R6G and Acr were measured using excitation wave-
lengths of 510 nm and 408 nm and emission wavelengths of 555 nm
and 450 nm, respectively. The excitation and emission bandpasses
were both set to 5 nm for R6G and Acr experiments.
The total ﬂuorescence intensity (FTotal) was calculated by combining
the polarization components from the polarization experiments as
shown in Eq. (1):
FTotal ¼ VV þ 2  VH  G ð1Þ
where VV and VH are the sample's ﬂuorescence polarization compo-
nents parallel and perpendicular to the excitation light, respectively,
and G is the G-factor for the instrument speciﬁc to the experimental
settings of each experiment.
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single site binding model:
F or FPð Þ ¼ F0 þ FMAX–F0ð Þ x Protein½  =KD þ Protein½  ð2Þ
where F (or FP) is the experimentally measured ﬂuorescence intensity
(or polarization), F0 is the ﬁtted ﬂuorescence intensity (or polarization)
in the absence of protein, FMAX is theﬁtted ﬂuorescence intensity (or po-
larization) when ethidium is fully bound, [Protein] is the protein con-
centration measured in μM, and KD is the ﬁtted dissociation constant
in μM units. Data were processed using the program OriginPro 7.5
using the recorded errors (sd) for weighting the data. For the KD value
determination in the presence of different DDM concentrations, the
binding data were collected at concentrations of 0.02, 0.10, 0.30, 0.50,
0.80 and 1.10% DDM by preparing Et, R6G and Acr buffers with the cor-
responding amount of DDM. The reported errors are the standard devi-
ation of the mean calculated from at least three experiments. The error
bars in Figs. 1, 2, and 4–6 are the standard deviations and those in Fig. 3
are the standard deviation of the means. The binding assays in C12E8
were performed as described for DDM, except that Anapoe-C12E8 was
used in place of DDM. These binding assays were carried out for two
substrates (Acr and R6G) at two concentrations (0.02% and 0.5%) of
Anapoe-C12E8.2.5. DDM binding assays
The effects of DDM on the ﬂuorescence intensity and polarization of
Et, R6G and Acr in the absence of protein were determined as follows.
Substrate (2 μM for Et and 1 μM for R6G and Acr) was added to 300 μl
of assay buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2 mM BME)
and dispensed into 11 Eppendorf tubes in 20 μl aliquots. Next a 40 μl
sample of substrate in assay buffer containing 10% (w/v) DDMwas pre-
pared and 20 μl dispensed into a tube and the remaining 20 μl was seri-
ally diluted into the tubes containing only assay buffer and substrate.
The ﬁnal tube was left unmixed and contained no detergent. Samples
were equilibrated and the ﬂuorescence data collected and analyzed as
described in Section 2.4, except that the KD values resulting from
Eq. (2)were expressed in units of % of DDM(w/v) and the term [Protein]
was replaced with [DDM], which is the concentration of DDM in the
sample expressed in % (w/v). The reported KD values are the average







Fig. 1. Substrates binding to DDMmicelles as monitored by FP. Representative FP data
are shown for the three substrates titrated with DDM. All three substrates show increases
in FPwith R6G (red) reaching thehighest FP value of 0.339± 0.005, followedby Et (black)
and Acr (cyan)withmaximumFP values of 0.269± 0.009 and 0.228± 0.002, respective-
ly. The detergent concentration is shown on a logarithmic scale.2.6. Correction of polarization values
The total ﬂuorescence intensity (F) of each ﬂuor (1 μM) was mea-
sured in the absence and presence of excess MepA protein (approx.
140 μM) using the parallel (VV) and perpendicular (VH) components
from the polarization experiments (Eq. (1)). The total ﬂuorescence in-
tensity, F, of each substrate was measured in three conditions: assay
buffer containing 0.02% DDM, assay buffer containing 10% DDM and in
the presence of concentratedMepA. From these intensities, the ﬂuores-
cence enhancement factor, g, was computed as shown in (Eq. (3))
[31–33]:
g ¼ F finalð Þ=F initialð Þ ð3Þ
where F(ﬁnal) represents ﬂuorescence intensity of the bound substrate,
and F(initial) is the intensity of the free substrate, according to the output
from OriginPro after the data are ﬁtted. We found that only Et showed
signiﬁcant enhancement of ﬂuorescence in the presence of either
DDM or MepA and proceeded to correct only the polarization data for
Et using Eq. (4) [31–33]:
x ¼ 3 –Pbð Þ Pi–P f
 
= 3−Pið Þ Pb–P f
 
þ g– 1ð Þ 3 –P f
 
Pb–Pið Þ ð4Þ
where x represents the fraction of ligand bound, Pf and Pb are the ﬁtted
polarization values of free and bound ligand, respectively, Pi is the
experimentally observed polarization value and g is the ﬂuorescence
enhancement factor (Eq. (3)). The corrected values were then ﬁtted to
a single site binding model as in Eq. (2).
2.7. Inhibition of Acr, Et & R6G Binding to MepA by TPP
Puriﬁed wild-type MepA preparations were ultra-centrifuged as de-
scribed above for previous polarization binding assays. The inhibition
experiments were carried out in buffer B at a MepA concentration of
5 μM, substrate concentration at 1 μM, and decreasing TPP concentra-
tion from 7.5 mM to 50 nM, including zero TPP (i.e. no inhibition) sam-
ple. Experiments for all three substrates were carried out in triplicate,
and the results were averaged and plotted. Excitation and emission
wavelengths, as well as band passes, were recorded as described in
previous polarization binding assays. Polarization data were ﬁtted to a
single site binding model using OriginPro 7.5.
3. Results
3.1. MepA activity assay
To ensure that the wild-type protein is active, we measured the
effect of protein expression on the accumulation of Et in E. coli. Cells
expressing active MepA are expected to accumulate less Et as a result
of the efﬂux activity of MepA. We compared the accumulation of Et in
the JW0451-2 cells (ΔacrB, KmR) expressing wild type MepA, D183A,
and a control set of JW0451-2 cells (ΔacrB, KmR) transformed with an
empty pBAD vector. We found lower accumulation of Et in cells
expressing WT MepA than in cells with the D183A mutation in MepA
or the pBAD vector alone (Fig. S2). These results are consistent with
activity assays done on other MATE transporters [16,17,34,35]. Protein
expression and puriﬁcation of D183A yield a similar amount of protein
to that of WT MepA puriﬁcation (Fig. S2). Cells expressing the D183A
construct had a similar amount of Et accumulated as the cells with the
control pBAD vector. The D183Amutation has been reported to be inac-
tive in S. aureus [23], and our results show that D183A is also inactive in
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Fig. 2. Enhancement of ﬂuorescence intensity of Et upon binding detergent orMepA. Representative curves of the increase in ﬂuorescence intensity of Et upon binding (A) to DDM in
the absence of protein, (B) toMepA in assay buffer containing 0.02%DDM, and (C) toMepA in assay buffer containing 1.1% DDM). The protein and the detergent concentrations are shown
on logarithmic scales.
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Fluorescence polarization (FP) experiments showed that all three
substrates interact directly with DDM micelles. The polarization in-
creases from 0.017 to 0.229 for Acr, from 0.032 to 0.339 for R6G, and
from 0.062 to a ﬁnal value of 0.265 for Et (Fig. 1 and Table 1). Similarly,
we ﬁnd that both Acr and R6G interact with C12E8 micelles (Fig. S3). In
the case of Et, its interactionwithDDMmicelles led to enhancedﬂuores-
cence intensity, indicating a higher quantum yield for Et upon binding
to the detergent. The average observed ﬂuorescence intensity increase
for Et was 3.69± 0.43 fold (Fig. 2). The average calculated ﬂuorescence
intensity increase for Et according to the output fromOriginPro after the
datawere ﬁttedwas 3.2±0.2 fold. As a result, the recorded polarization
values were corrected as described in themethod section (Eq. (4)). This0
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Fig. 3. The detergent effect on measured KDapp values. The afﬁnities of MepA for R6G
(red), Et (black) and Acr (cyan) at various DDM concentrations. Signiﬁcantly, at low
DDM concentration (0.02%), MepA appears to interact most tightly with R6G, followed
by Acr and Et. Whereas at DDM concentrations≥0.30%, the relative afﬁnities are reversed
with Acr and Et showing stronger interactions thanR6G. The apparent KD ofMepA for R6G
increases 20.9-fold. The apparent KDapp values for Et and Acr show smaller increases of 2.2
and 2.3 fold, respectively. For Et, the KDapp calculated from the corrected FP data is shown.was necessary due to the discrepancy in the quantum yields of the free
Et versus the micelle bound Et [31–33].
The association with the DDM micelles can be described as a
partitioning of the substrate between the aqueous buffer and the deter-
gent. The partition coefﬁcient (KDDM = [SubstrateDDM]/[Substratefree])
equals 1.0 at themid-point of the binding curvewhere half the substrate
is bound to micelles and the other half is free in solution. The partition
coefﬁcients (KDDM) equaled 1.0 at 0.618% DDM for Acr, 0.036% DDM
for R6G, and 0.386% DDM for Et before applying the correction and
1.23% DDM after the correction. Based on the ﬂuorescence enhance-
ment data for Et, we obtained a partition coefﬁcient value of 1.0 at
1.70% DDM. The partition coefﬁcients for C12E8 (KC12E8) equaled
1.0 at 0.218% C12E8 for Acr, and 0.054% C12E8 for R6G (Fig. S3).
3.3. Binding of substrates to MepA and the detergent effect
We ﬁnd that all three substrates bind to MepA. We carried out the
binding experiments between MepA and each of the three substrates
at 6 detergent concentrations (0.02, 0.10, 0.30, 0.50, 0.80, and 1.10%
DDM), to evaluate the potential interference of the detergent with the
binding assays (Fig. 3). We ﬁnd that the apparent KD values (KDapp) for
all three substrates were inﬂuenced by the amount of the detergent
used in the assay buffer. Surprisingly, the magnitude of this detergent
effect varied greatly among substrates (Figs. 3 and 4, Table 2). We
found the detergent effect to be large for R6G, whereas only relatively
minor effects were observed for Acr and Et. As a result, the ranking of
which substrate binds more tightly to MepA changes with increasing
detergent concentration. In order to minimize the detergent effect, typ-
ically these binding assays are done in buffers containing low detergent
concentrations, such as ~0.02% in the case of DDM. Under this “standard
condition”, we ﬁnd that R6G binds toMepAmore tightly than Et or Acr.
However, at high detergent concentrations (N0.50% DDM) R6G binds to
MepA more weakly than Et or Acr. The KDapp increased from the lowest
detergent concentration (0.02% DDM) to the highest detergentTable 1
Interactions between substrates and DDMmicelles.
Acr R6G Et
Initial FP 0.017 ± 0.004 0.032 ± 0.002 0.062 ± 0.005
Final FP 0.229 ± 0.017 0.339 ± 0.005 0.265 ± 0.009
DDM (%)a 0.618 ± 0.026 0.036 ± 0.005 0.386 ± 0.077b
1.23 ± 0.25c
1.70 ± 0.36d
a Detergent concentration at KDDM = 1.0.
b Calculated from raw polarization data.
c Calculated from corrected polarization data.
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Fig. 4. Substrates binding toWTMepA and D183A at 0.02% and 1.1%DDM. Representative FP data of substrates when titrated withMepA at the lowest and highest DDM concentrations
used (0.02% on left; 1.10% on right). Wild type MepA is shown in black and D183A is shown in red. The top panels show data for Acr. The center panels show data for Et, and the bottom
panels show data for R6G. The ΔFP for R6G at 1.1% DDM is small, and an inset is included to show the binding curve. The protein concentration is shown on a logarithmic scale.
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3.3-fold for Et before correction and 2.2-fold after correction
(Table 2). A similar increase in the KDapp of 1.8-fold was observed for
Et by calculating the KDapp values directly from the ﬂuorescence
enhancement data (Fig. S4).Table 2
Summary of substrates binding afﬁnities to WT MepA and D183A.
Variant DDM (%) KDapp (μM)
Acra R6Ga Eta Etb Etc
WT 0.02 6.0 ± 0.2 2.5 ± 0.1 1.8 ± 0.5 11.2 ± 1.8 10.1 ± 2.3
WT 0.10 6.4 ± 0.7 5.2 ± 0.3 1.9 ± 0.1 8.4 ± 0.4 8.5 ± 0.1
WT 0.30 8.1 ± 1.6 11.8 ± 0.9 2.3 ± 0.3 9.7 ± 0.5 9.6 ± 0.7
WT 0.50 8.3 ± 0.8 17.4 ± 1.1 3.0 ± 0.3 15.0 ± 2.4 12.9 ± 1.3
WT 0.80 10.5 ± 0.6 29.6 ± 3.3 4.4 ± 1.0 15.7 ± 3.0 18.5 ± 4.5
WT 1.10 13.7 ± 1.2 51.3 ± 6.0 5.8 ± 1.0 20.0 ± 1.9 21.9 ± 2.1
D183A 0.02 18.2 ± 0.8 1.8 ± 0.3 4.9 ± 0.1 55.7 ± 9.1 33.3 ± 3.8
a Afﬁnities calculated directly from polarization data.
b Afﬁnities calculated from total ﬂuorescence intensity.
c Afﬁnities calculated from corrected polarization values.Ethidiumpresented a special case because its ﬂuorescence increased
substantially (up to ~5.2 fold) when fully bound to MepA (Fig. 2). This
increase in ﬂuorescence intensity (g) required the application of a cor-
rection to the polarization data (Eq. (4)). The value of the enhancement
(g) decreased with increasing detergent concentration in the assay
buffer (Fig. S4). The quantum yields for Acr and R6G showed small
ﬂuctuations that were uncorrelated with the protein or detergent
concentrations.
MepA binding assays performed at high detergent concentrations
resulted in higher initial FP values. The initial FP values were measured
in the absence of protein. The increase in the initial FP values is indica-
tive of association between the substrates and the DDM micelles. The
initial FP values increased from 0.013 to 0.145 for Acr, from 0.072 to
0.326 for R6G, and from 0.041 to 0.195 for Et, just as a result of higher
detergent concentration in the assay buffer (Fig. 4 and Table 3). Despite
higher initial FP values, the addition of MepA resulted in further
increases in FP values, reﬂecting the substrates binding to a larger
molecular weight species. The MepA detergent complex is expected to
be larger than the free DDM micelles. The ﬁnal FP values remained
approximately the same for all detergent concentrations tested (Fig. 4
and Table 3).
Table 3
Detergent effect on initial and ﬁnal polarization values.
DDM (%) Initial FP Final FP
Acr R6G Et Acr R6G Et
0.02 0.013 ± 0.002 0.072 ± 0.001 0.041 ± 0.018 0.358 ± 0.001 0.387 ± 0.002 0.385 ± 0.014
0.10 0.040 ± 0.001 0.255 ± 0.007 0.099 ± 0.007 0.360 ± 0.003 0.388 ± 0.002 0.381 ± 0.011
0.30 0.079 ± 0.003 0.298 ± 0.002 0.134 ± 0.001 0.357 ± 0.006 0.393 ± 0.003 0.378 ± 0.012
0.50 0.115 ± 0.006 0.310 ± 0.004 0.160 ± 0.007 0.355 ± 0.006 0.396 ± 0.003 0.379 ± 0.013
0.80 0.122 ± 0.006 0.317 ± 0.001 0.173 ± 0.008 0.351 ± 0.002 0.392 ± 0.002 0.381 ± 0.015
1.10 0.145 ± 0.007 0.326 ± 0.001 0.195 ± 0.012 0.349 ± 0.002 0.394 ± 0.002 0.385 ± 0.012
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if the observed detergent effect is speciﬁc to DDM, or a more general
phenomenon. These experiments were performed on Acr and R6G at
two C12E8 concentrations (0.02% and 0.5%).We observed that at higher
C12E8 concentration, the KDapp increased for both substrates (Acr and
R6G). Interestingly, again we found that R6G was more greatly inﬂu-
enced by the change in the detergent concentration than Acr (Fig. 5).
The KDapp increased by 8.0-fold for R6G binding and by 3.5-fold for Acr
binding over a concentration range of 0.02% to 0.5% C12E8. In many of
the experiments carried out at higher detergent concentrations satura-
tions were not reached due to the lowered afﬁnity. As a result the
precision of reported KDapp values is less reliable in the cases of low
binding afﬁnities.3.4. D183A binding
The D183A mutation has been shown previously to be inactive in
S. aureus [23]. To investigate whether D183A affects binding, and
whether the FP binding assay used here is sensitive enough to detect
the potential effects of mutations on binding, we measured binding af-
ﬁnities of all three substrates to the D183Amutant MepA protein. Com-
pared to the wild type protein, we ﬁnd that D183A has weaker binding
with both Acr and Et (Fig. 4 and Table 2). To probe for potential deter-
gent interference, we measured the binding to D183 both at the lowest
DDM concentration (0.02%) and at the highest (1.10%). Binding of
D183AMepA toAcr and Etwasweaker thanwild typeMepA at both de-
tergent concentrations (Fig. 4). In the case of R6G, no effect on binding








Fig. 5. The detergent effect onmeasuredKDapp values in C12E8. The KDapp values between Acr an
concentration is increased from 0.02% (red) to 0.5% (black). The KDapp values between R6G andM
concentration is increased from 0.02% (red) to 0.5% (black).3.5. Inhibition assay
To conﬁrm that we are observing substrate binding to a speciﬁc
MepA site, we carried out an inhibition experiment with TPP. We
observe a loss of FP with increasing concentrations of TPP for all three
substrates (Fig. 6). This is consistent with results observed for TPP inhi-
bition of R6G binding to NorM [36]. The inhibition data reﬂect that TPP
competes out all three substrates from a speciﬁc binding site.4. Discussion
Herewe report theﬁrst expression, puriﬁcation and characterization
of the S. aureusmultidrug transporter MepA.We examined the effect of
detergent on the binding betweenMepA and three of its substrates, and
we found that the effect of the detergent concentration was highly sub-
strate dependent. The detergent concentration had a large impact on
the binding of R6G to MepA, and only a slight effect on the binding of
Acr and Et to MepA. All three substrates showed an upward trend in
the KDapp values with increasing detergent concentration. The increases
in the KDapp values ﬁt a linear relationship with the concentration of
the detergent (Fig. 3). The slopes of these lines reﬂect the extent of
the “detergent effect” on binding. Acr and Et have similar slopes with
modest inclines, whereas a signiﬁcantly larger incline was observed
for R6G.
Increasing the detergent concentration can impact the behavior of
both the protein as well as the substrate. However, the effect on KDapp
values appears to be mainly a result of the inﬂuence of the detergent
on the substrates, since the effect is highly substrate dependent.R6G
MepA (µM)
0.1 1.0 10 100
dMepA (left panel) increased 3.5-fold from 31.3± 3.6 to 109.1± 3.5 μMwhen the C12E8












Fig. 6. Inhibition assay. Inhibition of Acr (cyan), Et (black), and R6G (red) binding to WT MepA using TPP. The TPP concentration is shown on a logarithmic scale.
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the substrates to the detergent micelles themselves (Fig. 1). Comparing
the assays done at 1.1% DDM to those done at 0.02% DDM it was
revealed that the KDapp values for Acr, Et, and R6G change by 2.3, 2.2
and 20.9 fold, respectively. As a result of the considerably differing ex-
tents of detergent effect, an important observation comes into light. At
lower detergent concentrations, R6G appears to have a higher afﬁnity
forMepA than either Acr or Et. However, at higher DDMconcentrations,
Acr and Et have a higher afﬁnity for MepA than R6G. The implications of
this reversal in relative afﬁnities can be signiﬁcant for drug design. A
similar behavior is observed in another detergent (C12E8), with R6G
having a bigger change in KDapp than that measured for Acr upon binding
toMepA as a result of increasing the detergent concentration. Addition-
ally, differences in the KDapp were observed depending on the detergent
used (DDM vs. C12E8). This highlights that the KDapp can be dependent
on the detergent selected for the experiments in addition to the concen-
tration of the detergent.
Previously reported afﬁnities between multidrug transporters and
their substrates are in the range observed for MepA at low detergent
concentration (0.02% DDM) [18,36–38]. Additionally, the ranking of
substrates is also the same as what we observe at lowest detergent
concentration (0.02% DDM), with R6G appearing to have the highest
afﬁnity toward the various transporters. For example, AcrB was shown
to have KD values of 5.5 ± 0.9 μM and 8.7 ± 1.9 μM toward R6G and
Et, respectively [37]. The MATE transporters NorM and YdhE also be-
haved similarly. NorM was reported to have KDs of 3.4 ± 0.2 μM and
12.3 ± 1.3 μM to R6G and Et, respectively, and YDhE was reported to
have KDs of 3.0 ± 0.2 μM and 9.8 ± 0.9 μM to R6G and Et, respectively
[36].
Prior assessments of detergent inﬂuence on substrate binding in
similar systems have had varying results. It was reported that the deter-
gent had no effect on NorM or YdhE's binding to R6G [36], and little
effect on AcrB binding to R6G [37]. A different aspect of the impact
of the detergent was observed for EmrE. Changing the detergent
from DDM to nonyl-glucoside had a large effect on the afﬁnity of
EmrE (12–26 fold) toward TPP [39]. Other reports suggest that deter-
gents can block substrate binding [40,41]. Based on the literature and
results reported here, we ﬁnd that although the detergent effect may
be common, it is not universal. Therefore, it is important to examine
eachmembrane proteinwith each substrate and detergent combination
individually. Results fromothermembrane protein systems support this
conclusion. For example, the detergent concentration was shown to in-
ﬂuence protein stability in the case of FsrC [42]. Additionally, in the case
of the multidrug transporter SugE, it was shown that interactions with
the ligands were detergent-dependent [43].
Ethidium presented a special case, because its ﬂuorescence intensity
increased as a result of binding toMepA or to DDMmicelles. Due to thisincrease in quantum yield, the ﬂuorescence of the bound Et was stron-
ger than the ﬂuorescence of the free Et, which skewed the polarization
signal. Therefore, we corrected the polarization data removing the bias
introduced by the enhanced ﬂuorescence intensities [31–33]. As a re-
sult, not only does an increase in DDM concentration inﬂuence the ap-
parent KDapp, but it also affects the correction factor applied to the FP
data (Fig. S4).
The increase of the quantum yield of Et is not unusual. It has been
previously reported that water molecules quench the ﬂuorescence of
Et, so when Et is in a hydrophobic environment its measured ﬂuores-
cence intensity increases [44]. Therefore, this quantum yield enhance-
ment is not limited to MepA binding but is expected to be a general
ﬂuorescence property of Et. The KDapp values changed substantially
upon applying the correction factor. For example, at 0.02% DDM the
KDapp was corrected from 2.7 μM to 15.5 μM. Consequently, it is essential
to consider changes in the quantum yield when taking polarization
measurements. At the same time, the increase in ﬂuorescence offered
additional data to observe the binding process. The increase in ﬂuores-
cence appeared to be a direct consequence of binding to MepA and
here itwasdemonstrated that it can be effectively used for themeasure-
ment of apparent KD values. Remarkably, the Et KDapp values that were
measured from the enhancement data were in large agreement with
those obtained from the corrected FP experiments (Fig. S4). Therefore,
the change in the ﬂuorescence intensity of Et requires the correction
of FP data, and at the same time it can also offer an additional tool for
monitoring the binding event.
The MepA D183A mutation showed a similar degree of lowered af-
ﬁnity toward Acr and Et, but no apparent effect on R6G binding
(Table 2). A number of recent structures of MATE proteins have been
determined, some with their substrates bound [18–20]. In all these
structures the corresponding position for D183A is not close to the
substrate binding site [23]. It is plausible that in a new uncharacterized
protein conformation, D183A may interact directly with the substrates.
However, the available structural data suggest that D183A does not
interact with the substrates, and therefore the inﬂuence of D183A on
substrate bindingmay be due to conformational effects or indirect inter-
actions. Although FP is commonly used to measure the binding of
hydrophobic substrates to various MATE transporters, the detection of
the effect of mutations on binding using FP is novel to these systems.
Here we show that FP is sensitive enough to detect the effects of a
point mutation on substrate binding, however this sensitivity may be
substrate dependent. The lack of effect on R6G binding may be due to
the high detergent effect which may mask the effect of the mutation.
We ﬁnd that binding assays donewith Acr and Etmay bemore sensitive
to the effects of mutations on binding. This is the ﬁrst report using FP to
observe the effect of a mutation on substrate binding for any MATE
transporter.
2546 C. Banchs et al. / Biochimica et Biophysica Acta 1838 (2014) 2539–25465. Conclusions
We determined the afﬁnity of MepA to three of its substrates at var-
ious detergent concentrations. We ﬁnd that the detergent interference
is highly substrate speciﬁc. In the case of MepA, we demonstrated that
Acr and Etwere only slightly inﬂuenced by the detergent concentration,
whereas R6G was highly sensitive. We also showed that the afﬁnity of
the substrate to the detergent correlates with the degree of the deter-
gent effect on binding. Similar behavior was observed when C12E8
was used as a detergent. We ﬁnd that the effect of the detergent on
the binding of a hydrophobic substrate to a membrane protein needs
to be examined on a case-by-case basis.We showed that D183 is impor-
tant for substrate binding, despite being distant from the predicted
binding site. We also ﬁnd that the FP assays can be sensitive enough
to detect the effects of point mutations on binding.
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